Piermont Capital Management’s Eastman Chemical EMN Stock Holding History

Piermont Capital Management’s Portfolio EMN Stock Details EMN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-6,480	Closed	-$648K	–	137
2018 Q2	$648K	Hold	6,480	–	–	0.2%	132
2018 Q1	$684K	Buy	6,480 +590	+10%	+$59.7K	0.23%	128
2017 Q4	$546K	Hold	5,890	–	–	0.18%	146
2017 Q3	$533K	Sell	5,890 -3,800	-39%	-$323K	0.18%	152
2017 Q2	$814K	Hold	9,690	–	–	0.23%	181
2017 Q1	$783K	Buy	+9,690	New	+$762K	0.19%	189

Other funds holding EMN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Piermont Capital Management's EMN Position: Q3 2018 in Review

Piermont Capital Management sold out of Eastman Chemical (EMN) in Q3 2018, closing a stake of 6,480 shares — an estimated $648K sold.

Piermont Capital Management first reported a position in EMN in Q1 2017 and held it in 6 quarters. The position peaked at $814K in Q2 2017. 697 funds tracked by Wall St. Rank hold EMN as of Q3 2018.

Piermont Capital Management reported no remaining Eastman Chemical position as of Q3 2018 after selling out during the quarter.
Piermont Capital Management sold 6,480 Eastman Chemical shares in Q3 2018, an estimated $648K.
Piermont Capital Management first reported a position in Eastman Chemical in Q1 2017 and held it in 6 quarters.
Piermont Capital Management's Eastman Chemical position peaked at $814K in Q2 2017.
697 funds tracked by Wall St. Rank held Eastman Chemical as of Q3 2018.

Based on Piermont Capital Management's 13F filing for Q3 2018, filed 6 Nov 2018.